Klinger H, Yamamoto T, Stevens L M. "Method for the Synthesis of Rivaroxaban Impurity 213" [P]. US Patent, US 9310683 B2, 2021-08-06.
发明人杨光,黄志刚,沈红梅. "A Process for Preparing High-Purity Rivaroxaban Impurity 213" [P]. 中国发明专利, 专利号 CN 113179663 B, 授权公告日 2017-06-09.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质213 in Pharmaceutical Formulations". Biomed. Chromatogr., 2010, 370, (3), 3350-3370.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质213 as an Impurity". Food Chem., 2014, 343, (1), 3078-3092.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 213 Using HRMS and NMR". J. Agric. Food Chem., 2013, 1088, 6971-7000.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 利伐沙班杂质213 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2020, 2099, 2046-2062.